An estimated 70% of patients with stage 3 lung cancer do not see their tumors respond to standard treatment. An expert explains why, and what a new approach aims to change.
Dr. David DiBardino
Advertisement
Articles by Dr. David DiBardino
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
Blood Cancer Treatments in the FDA Pipeline: What Could Come Next
2
3 More Lung Cancer Breakthroughs From WCLC 2026
3
Myeloma Guidelines Call for Yearly Measurable Residual Disease Testing
4
The Service Dog Who Helped Me Keep Fighting
5